KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jazz Pharmaceuticals (JAZZ) Change in Acquisitions & Divestments (2016 - 2025)

Jazz Pharmaceuticals (JAZZ) has 11 years of Change in Acquisitions & Divestments data on record, last reported at $180.0 million in Q4 2025.

  • For Q4 2025, Change in Acquisitions & Divestments fell 37.93% year-over-year to $180.0 million; the TTM value through Dec 2025 reached $1.4 billion, up 60.95%, while the annual FY2025 figure was $1.4 billion, 60.95% up from the prior year.
  • Change in Acquisitions & Divestments reached $180.0 million in Q4 2025 per JAZZ's latest filing, down from $400.0 million in the prior quarter.
  • Across five years, Change in Acquisitions & Divestments topped out at $760.0 million in Q1 2021 and bottomed at $20.0 million in Q3 2023.
  • Average Change in Acquisitions & Divestments over 5 years is $279.2 million, with a median of $290.0 million recorded in 2024.
  • Peak YoY movement for Change in Acquisitions & Divestments: skyrocketed 1675.0% in 2024, then plummeted 37.93% in 2025.
  • A 5-year view of Change in Acquisitions & Divestments shows it stood at $335.0 million in 2021, then tumbled by 82.09% to $60.0 million in 2022, then skyrocketed by 316.67% to $250.0 million in 2023, then increased by 16.0% to $290.0 million in 2024, then tumbled by 37.93% to $180.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Change in Acquisitions & Divestments were $180.0 million in Q4 2025, $400.0 million in Q3 2025, and $470.0 million in Q2 2025.